Tiny testers: new insulin pump safety checked in kids as young as 2

NCT ID NCT06604871

Completed Disease control Sponsor: Medtronic MiniMed, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 19, 2026 · Updated 26 times

Summary

This study tested the safety of a new automated insulin pump and glucose monitor system for very young children with type 1 diabetes. It involved 56 children aged 2 to 6 years who used the device system at home for about four months. The main goal was to see how safe the system was and to check for any serious side effects related to diabetes management.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Barbara Davis Center for Childhood Diabetes

Aurora, Colorado, 80045, United States
Nemours Childrens Specialty Care

Jacksonville, Florida, 32207, United States
Stanford University

Palo Alto, California, 94304, United States
Texas Childrens Hospital

Houston, Texas, 77030, United States
UCSF The Madison Clinic for Pediatric Diabetes

San Francisco, California, 94158, United States
USF Diabetes and Endocrinology Center

Tampa, Florida, 33612, United States
University Hospitals Cleveland Medical Center

Cleveland, Ohio, 44106, United States
Yale School of Medicine

New Haven, Connecticut, 06511, United States

Conditions

Explore the condition pages connected to this study.

TYPE 1 DIABETES